Relative deficiency of acidic isoforms of osteopontin from stone former urine
- PMID: 22322528
- PMCID: PMC4978133
- DOI: 10.1007/s00240-012-0459-1
Relative deficiency of acidic isoforms of osteopontin from stone former urine
Abstract
We have tested the relative electrophoretic mobility of osteopontin (OPN) isolated from urine obtained from normal individuals (NU) against similar samples derived from the urine of stone formers (SFU) using high-resolution isoelectric focusing (isoelectric point, pI range 3.5-4.5) in 2D electrophoresis, with Western blot detection. We also report the results from competitive ELISA analyses of these samples. We demonstrated that human urinary OPN has a discrete four band separation pattern that conforms to four previously documented OPN isoforms. The lower two M(r) isoforms migrate to a greater degree toward the acidic end of the gel than do the higher two M(r) isoforms. Densitometry of the signal reveals significant difference in the migration pattern of OPN from SFU as compared to that from NU based on an analysis of the spot intensities grouped in 0.1 pI unit increments. A novel method for the calculation of a weight-averaged pI based on the relative signal strength in an OPN 2D Western blot was developed. The analysis revealed a significantly increased weight-averaged pI values for the higher M(r) forms of OPN in the stone former compared to normal population. Additionally, alkaline phosphatase-treated NU samples resulted in a significant average pI shift of 0.05 units in the alkaline direction, suggesting that a decrease in the average degree of phosphorylation could be responsible for the difference between NU and SFU pI.
Figures



Similar articles
-
Quantification of osteopontin in the urine of healthy and stone-forming men.Urol Res. 1999 Aug;27(4):225-30. doi: 10.1007/s002400050114. Urol Res. 1999. PMID: 10460890
-
The Impact of Glycosylation of Osteopontin on Urinary Stone Formation.Int J Mol Sci. 2019 Dec 21;21(1):93. doi: 10.3390/ijms21010093. Int J Mol Sci. 2019. PMID: 31877766 Free PMC article.
-
Low-molecular-weight variants of osteopontin generated by serine proteinases in urine of patients with kidney stones.J Cell Biochem. 1996 Jun 1;61(3):402-9. doi: 10.1002/(sici)1097-4644(19960601)61:3<402::aid-jcb7>3.0.co;2-x. J Cell Biochem. 1996. PMID: 8761944
-
Roles of osteopontin gene polymorphism (rs1126616), osteopontin levels in urine and serum, and the risk of urolithiasis: a meta-analysis.Biomed Res Int. 2015;2015:315043. doi: 10.1155/2015/315043. Epub 2015 Feb 15. Biomed Res Int. 2015. PMID: 25785266 Free PMC article. Review.
-
[Osteopontin in systemic lupus erythematosus].Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(2):118-123. doi: 10.2177/jsci.40.118. Nihon Rinsho Meneki Gakkai Kaishi. 2017. PMID: 28603202 Review. Japanese.
Cited by
-
Alteration of urinary macromolecules by adsorption on surfaces, probably an important factor in urolithiasis.Urolithiasis. 2013 Nov;41(6):467-74. doi: 10.1007/s00240-013-0604-5. Epub 2013 Sep 14. Urolithiasis. 2013. PMID: 24036974
-
Development of a two-stage in vitro model system to investigate the mineralization mechanisms involved in idiopathic stone formation: stage 1-biomimetic Randall's plaque using decellularized porcine kidneys.Urolithiasis. 2019 Aug;47(4):321-334. doi: 10.1007/s00240-018-1060-z. Epub 2018 May 18. Urolithiasis. 2019. PMID: 29777258 Free PMC article.
-
Comparison of 30 Cytokines in Human Breast Milk between 1989 and 2013 in Japan.Nutrients. 2023 Apr 1;15(7):1735. doi: 10.3390/nu15071735. Nutrients. 2023. PMID: 37049575 Free PMC article.
-
Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight.Cells. 2019 Aug 2;8(8):815. doi: 10.3390/cells8080815. Cells. 2019. PMID: 31382483 Free PMC article. Review.
-
Biomimetic Randall's plaque as an in vitro model system for studying the role of acidic biopolymers in idiopathic stone formation.Urolithiasis. 2015 Jan;43 Suppl 1(0 1):77-92. doi: 10.1007/s00240-014-0704-x. Epub 2014 Aug 15. Urolithiasis. 2015. PMID: 25119505 Free PMC article.
References
-
- Khan SR, Kok DJ. Modulators of urinary stone formation. Front Biosci. 2004;9:1450–1482. - PubMed
-
- Worcester EM, Blumenthal SS, Beshensky AM, Lewand DL. The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res. 1992;7:1029–1036. - PubMed
-
- Worcester EM, Beshensky AM. Osteopontin inhibits nucleation of calcium oxalate crystals. Ann N Y Acad Sci. 1995;760:375–377. - PubMed
-
- Lieske JC, Leonard R, Toback FG. Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol (Ren Fluid Electrolyte Physiol) 1995;268(37):F604–F612. - PubMed
-
- Wesson JA, Johnson RJMM, Beshensky AM, Stietz S, Giachelli C, Liaw L, Alpers CE, Couser WG, Kleinman JG, Hughes J. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol. 2003;14:139–147. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous